Search results

1 – 10 of 15
Expert briefing
Publication date: 26 February 2016

The risks of liberalising the pharmaceuticals market.

Expert briefing
Publication date: 4 July 2018

Contribution of healthcare sector to Greece’s recovery.

Expert briefing
Publication date: 27 August 2021

Brazil, one of the hardest-hit countries, has a long history of policy and practice aimed at matching universal healthcare with sustainable local supply. Successful technological…

Details

DOI: 10.1108/OXAN-DB263756

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 9 April 2021

Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports…

Expert briefing
Publication date: 23 March 2021

This is partly attributed to age and to health predispositions, but the physiological basis is not entirely clear. Existing immunity from previous exposure to other coronaviruses…

Details

DOI: 10.1108/OXAN-DB260364

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 5 February 2021

The vaccine is one of four being developed by Cuba, which aims to become a key international vaccine supplier, to enhance the strategic and economic impacts of its health…

Expert briefing
Publication date: 6 March 2018

Cancer advances.

Details

DOI: 10.1108/OXAN-DB230203

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 12 May 2023

The previous all-time peak was recorded in 2020, with a total of 58,435 confirmed cases. At the same time, an all-time record 53 deaths have been reported so far this year -…

Details

DOI: 10.1108/OXAN-DB278894

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 13 May 2021

Priority groups -- including health professionals, indigenous people, the elderly and those with co-morbidities, teachers, security and prison staff, prisoners and the homeless -…

Expert briefing
Publication date: 12 January 2021

Earlier this month, the Drugs Controller General of India (DCGI) approved the Oxford/AstraZeneca vaccine, marketed in India as ‘Covishield’, and a locally developed jab. The…

Access

Year

Content type

Expert briefing (15)
1 – 10 of 15